<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with antithrombin III (ATT) deficiency after arterial embolism manifested an increasing requirement for <z:chebi fb="5" ids="28304">heparin</z:chebi> to adjust a partial thromboplastin time </plain></SENT>
<SENT sid="1" pm="."><plain>This was corrected by dramatically increasing doses of <z:chebi fb="5" ids="28304">heparin</z:chebi> and by conversion to <z:chebi fb="0" ids="10034">warfarin sodium</z:chebi>. "<z:chebi fb="5" ids="28304">Heparin</z:chebi>-resistance" should direct the physician to examine antithrombin III levels, and ATT levels should be determined as a baseline before anticoagulation therapy </plain></SENT>
</text></document>